<DOC>
	<DOCNO>NCT03105479</DOCNO>
	<brief_summary>Cadazolid demonstrate activity bacteria name Clostridium difficile animal study . The result first study conduct adult patient suggest efficacy new antibiotic , cadazolid , treatment diarrhea cause bacteria . This first study cadazolid child . The overall purpose study provide reassurance safety efficacy cadazolid child suffer infection due Clostridium difficile .</brief_summary>
	<brief_title>Comparison Cadazolid Versus Vancomycin Children With Clostridium Difficile-associated Diarrhea ( CDAD )</brief_title>
	<detailed_description>This multicenter , study run two part . Both part run consecutive age cohort , start old age category ( 12 &lt; 18 year old ) young ( birth &lt; 3 month ) . - Part A open-label , dose find part conduct least 24 subject . - Part B follow randomize , assessor-blinded , parallel-group design vancomycin use active comparator . Part B conduct 176 child . In part , treatment period 10 day follow Follow-up period 28-32 day .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Oxazolidinones</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>Key Signed informed consent parent legally authorize representative ( LAR ) assent child accord local requirement prior initiation studymandated procedure . Male female birth &lt; 18 year age , diagnose Clostridium Difficileassociated diarrhea ( CDAD ) . Females childbearing potential must negative pregnancy test screening must agree use adequate reliable method contraception . Key Positive Rotavirus test subject &lt; 5 year . Fulminant lifethreatening CDAD . More one previous episode CDAD 3 month period prior enrollment / randomization . Antimicrobial treatment active CDAD administer within 24 h prior screen except metronidazole treatment failure ( MTF ) . Subjects body weight &lt; 3 kg . Inflammatory bowel disease , chronic abdominal pain , chronic diarrhea etiology . Fecal microbiota transplant ( FMT ) , immunoglobulin therapy , investigational drug prevent treat CDAD within 1 month period ( 5 halflives case investigational drug , whichever long ) prior enrollment / randomization . Monoclonal antibody C. difficile within 6 month prior enrollment / randomization . Previous vaccination C. difficile . Known mental disorder . Any circumstance condition , , opinion investigator , may affect subject 's full participation study , compliance protocol .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>vancomycin</keyword>
	<keyword>child</keyword>
	<keyword>cadazolid</keyword>
	<keyword>clostridium difficile associate diarrhea</keyword>
</DOC>